in gynecologic cancers madrid, 11 may, 2018 · meeting directors: dr. francisco javier de santiago...

Meeting Directors:Dr. Francisco Javier de Santiago · MD Anderson Cancer Center Madrid, Spain

Dr. Robert L. Coleman · The University of Texas MD Anderson Cancer Center, Houston, USADr. Raúl Márquez · MD Anderson Cancer Center Madrid, Spain

Dr. Shannon N. Westin · The University of Texas MD Anderson Cancer Center, Houston, USA

Registrations: www.mdanderson.es/embracingnewstandards

6th

MD ANDERSON INTERNATIONAL MEETING IN

I N G Y N E C O L O G I C C A N C E R SEMBRACING NEW STANDARDS OF CARE

@MDAnderson_ES

PRELIMINARY PROGRAM

Madrid, 9th -11th May, 2018

6th

MD ANDERSON INTERNATIONAL MEETING IN

I N G Y N E C O L O G I C C A N C E R SEMBRACING NEW STANDARDS OF CARE

ANDERSON

I N G Y N E CEMBRACING N

MMD AAANNN

11:00 - 11:15 WELCOME AND INTRODUCTION Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain Dr. Robert L. Coleman The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain

SURGERY IN OVARIAN CANCERModerators:

Dr. Robert L. ColemanThe University of Texas MD Anderson Cancer Center, Houston, USA

Dr. Francisco Javier de SantiagoMD Anderson Cancer Center Madrid, Spain

11:15 - 11:35 Surgical trials in gynecologic oncology. A critical appraisal Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic

11:35 - 11:55 Laparoscopy in interval debulking surgery in ovarian cancer Dr. Giovanni Aletti Istituto Europeo di Oncologia, Milan, Italy

11:55 - 12:15 Ovarian cancer. Moon shot program Dr. Anil Sood The University of Texas MD Anderson Cancer Center, Houston, USA

12:15 - 12:35 Early recovery after surgery program (ERAS) Dr. Larissa A. Meyer The University of Texas MD Anderson Cancer Center, Houston, USA

12:35 - 13:00 Questions & Discussion

LIST OF FACULTY

Wednesday, May 9th, 2018

Dr. Giovanni AlettiIstituto Europeo di Oncologia, Milan, Italy

Dr. Sonsoles AlonsoMD Anderson Cancer Center Madrid, Spain

Dr. Alessandro BudaSan Gerardo Hospital, Monza, Italy

Dr. Natalia CarballoMD Anderson Cancer Center Madrid, Spain

Dr. Antonio CasadoHospital Clínico Univ. San Carlos, Madrid, Spain

Dr. David CibulaGeneral University Hospital and Charles University in Prague, The Czech Republic



Dr. Santiago DomingoHospital Univ. i Politècnic La Fe, Valencia, Spain

Dr. María Fernández-ChereguiniMD Anderson Cancer Center Madrid, Spain

Dr. Gwenaël FerronInstitut Claudius Regaud - IUCT Oncopole, Toulouse, France

Dr. David GershensonThe University of Texas MD Anderson Cancer Center, Houston, USA

Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France

Dr. Michael J. HalaskaCharles University in Prague,The Czech Republic

Dr. Amir Anthony JazaeriThe University of Texas MD Anderson Cancer Center, Houston, USA

Dr. Vesna KesicClinical Center of Serbia, Belgrade, Serbia

Dr. K. Rainer KimmigEssen University Hospital, Essen, Germany

Dr. Raúl MárquezMD Anderson Cancer Center Madrid, Spain

Dr. Sergio MartínezHospital Univ. Germans Trias i Pujol, Barcelona, Spain

Dr. Larissa A. MeyerThe University of Texas MD Anderson Cancer Center, Houston, USA

Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center, Phoenix, USA

Dr. Gema MorenoMD Anderson Cancer Center Madrid, Spain

Dr. Jordi PonceHospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain

Dr. Andrés PovedaFundación Instituto Valenciano de Oncología, Valencia, Spain

Dr. Eric Pujade-LauraineHôpital Hôtel-Dieu, Paris, France

Dr. Jose Alejandro Rauh-HainThe University of Texas MD Anderson Cancer Center, Houston, USA

Dr. Brian M. SlomovitzUniversity of Miami Hospital, Miami, USA

Dr. Anil SoodThe University of Texas MD Anderson Cancer Center, Houston, USA

Dr. Gemma ToledoMD Anderson Cancer Center Madrid, Spain

Dr. Shannon N. WestinThe University of Texas MD Anderson Cancer Center, Houston, USA

CONTROVERSIES IN FRONTLINE OVARIAN CANCERModerators:

Dr. Jordi PonceHospital Universitari de Bellvitge, L’Hospitalet de Llobregat, Barcelona, Spain

Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France

17:40 - 18:00 Guided lymphadenectomy in ovarian cancer. Any sense in LION´s era? Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany

18:00 - 18:30 Debate: IP chemotherapy in ovarian cancer18:00 - 18:15 Pro Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain

18:15 - 18:30 Against Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical

Center, Phoenix, USA


KEYNOTE LECTUREModerator:


13:00 - 13:40 Target microenvironmental opportunities in ovarian cancer Dr. Robert L. Coleman The University of Texas MD Anderson Cancer Center, Houston, USA

13:40 - 15:10 Lunch

FIRST LINE TREATMENT OF OVARIAN CANCER.TARGET DISCOVERY AND NOVEL THERAPEUTICS

Moderators:Dr. Raúl Márquez

MD Anderson Cancer Center Madrid, SpainDr. Giovanni Aletti

Istituto Europeo di Oncologia, Milan, Italy

15:10 - 15:30 Predicting resectability for primary debulking surgery in MD Anderson Cancer Center Madrid

Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain

15:30 - 15:50 Principles and concepts of cytoreductive surgery. Importance of surgical training

Dr. Sergio Martínez Hospital Univ. Germans Trias i Pujol, Barcelona, Spain

15:50 - 16:10 Optimal setting for antiangiogenic agents in first line. Evidence or preference

Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical


16:10 - 16:30 Neoadjuvant setting Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain

16:30 - 16:50 HIPEC. Do we have any evidence so far? Dr. Laurence Gladieff Institut Claudius Regaud - IUCT Oncopole, Toulouse, France


17:10 - 17:40 Coffee break

11:30 - 12:00 Stage Ib2 cervical cancer. Other options than chemoradiation

11:30 - 11:45 Radiotherapist Dr. Natalia Carballo MD Anderson Cancer Center Madrid, Spain

11:45 - 12:00 Gynecologic oncologist Dr. Michael J. Halaska Charles University in Prague, The Czech Republic


KEYNOTE LECTUREModerator:

Dr. Raúl MárquezMD Anderson Cancer Center Madrid, Spain

12:30 - 13:15 Inmunotherapy updates: can we use inmune system to treat gynecological cancer?

Dr. Amir Anthony Jazaeri The University of Texas MD Anderson Cancer Center, Houston, USA

13:15 - 14:45 Lunch

ENDOMETRIAL CANCERModerators:

Dr. Sergio MartínezHospital Univ. Germans Trias i Pujol, Barcelona, Spain


14:45 - 15:05 Update on conservative treatment. Ongoing trials Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA

15:05 - 15:45 The genomic data to clinical application in endometrial cancer patients. Clinical cases

Dr. Gema Moreno MD Anderson Cancer Center Madrid, Spain Dr. Sonsoles Alonso MD Anderson Cancer Center Madrid, Spain

CHALLENGING CASES IN GYNECOLOGICAL CANCERModerators:

Dr. Eric Pujade-LauraineHôpital Hôtel-Dieu, Paris, France

Dr. Santiago DomingoHospital Univ. i Politècnic La Fe, Valencia, Spain

08:30 - 08:50 Management of advanced stage and recurrent low grade serous ovarian cancer

Dr. David Gershenson The University of Texas MD Anderson Cancer Center, Houston, USA

08:50 - 09:10 Finding the patient for pelvic exenteration Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France

09:10 - 09:30 Contemporary management of uterine leiomyosarcoma Dr. Jose Alejandro Rauh-Hain The University of Texas MD Anderson Cancer Center, Houston, USA



CERVICAL CANCERModerators:

Dr. Gwenaël FerronInstitut Claudius Regaud - IUCT Oncopole, Toulouse, France


10:30 - 11:00 Contemporary management of advanced and recurrent cervical cancer

Dr. Bradley J. Monk Creighton University School of Medicine at St. Joseph’s Hospital and Medical


11:00 - 11:30 Rationale for only sentinel node in cervical cancer. Must we subselect patients? Dr. David Cibula General University Hospital and Charles University in Prague, The Czech Republic

Thursday, May 10th, 2018

MISCELLANEOUSModerators:

Dr. Sonsoles AlonsoMD Anderson Cancer Center Madrid, Spain

Dr. María Fernández-ChereguiniMD Anderson Cancer Center Madrid, Spain

08:30 - 08:50 Universal genetic testing Dr. Shannon N. Westin The University of Texas MD Anderson Cancer Center, Houston, USA

08:50 - 09:10 Social and psycological support Dr. Vesna Kesic Clinical Center of Serbia, Belgrade, Serbia

09:10 - 09:30 Quality of life and patient reported outcomes. How do they inform clinical trials? Dr. Larissa A. Meyer The University of Texas MD Anderson Cancer Center, Houston, USA


09:45 - 10:45TUMOR BOARD

Moderators:Dr. Francisco Javier de Santiago

MD Anderson Cancer Center Madrid, SpainDr. Robert L. Coleman

The University of Texas MD Anderson Cancer Center, Houston, USADr. Raúl Márquez

MD Anderson Cancer Center Madrid, Spain

Panel:Dr. David Gershenson

Dr. David CibulaDr. Gemma Toledo

Dr. Eric Pujade-LauraineDr. Anil Sood

Dr. Shannon N. WestinDr. Natalia Carballo


15:45 - 16:25 Stage IIIC2 endometrial cancer15:45 - 16:05 Radiotherapy Dr. Natalia Carballo MD Anderson Cancer Center Madrid, Spain

16:05 - 16:25 Chemotherapy Dr. Brian M. Slomovitz University of Miami Hospital, Miami, USA

16:25 - 16:45 Sentinel node mapping algorithm versus selective lymphadenectomy in early stage endometrial cancer

Dr. Alessandro Buda San Gerardo Hospital, Monza, Italy

16:45 - 17:05 ICG guided peritoneal mesometrial resection with targeted compartmental lymphadenectomy in endometrial cancer

Dr. K. Rainer Kimmig Essen University Hospital, Essen, Germany



PERSONALIZING DECISIONS IN RECURRENT GYNECOLOGIC CANCER TREATMENT

Moderators:Dr. David Gershenson

The University of Texas MD Anderson Cancer Center, Houston, USADr. Amir Anthony Jazaeri

The University of Texas MD Anderson Cancer Center, Houston, USA

18:05 - 18:25 Prolonging PFS with non-platinum in ovarian cancer Dr. Antonio Casado Hospital Clínico Univ. San Carlos, Madrid, Spain

18:25 - 18:45 PARPi’s: Where are we and where are we going? Dr. Andrés Poveda Fundación Instituto Valenciano de Oncología, Valencia, Spain

18:45 - 19:05 Treatments in novel targets in the recurrent setting Dr. Eric Pujade-Lauraine Hôpital Hôtel-Dieu, Paris, France


Friday, May 11th, 2018

11:15 - 14:00VIDEO WORKSHOP

11:15 - 12:45 EXPERTS

11:15 - 11:45 Open surgery Dr. Gwenaël Ferron Institut Claudius Regaud - IUCT Oncopole, Toulouse, France

11:45 - 12:15 Laparoscopic surgery Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain

12:15 - 12:45 Robotic surgery Dr. Jose Alejandro Rauh-Hain The University of Texas MD Anderson Cancer Center, Houston, USA

12:45 - 14:00 YOUNG SURGEONS

First MD Anderson Cancer Center Madrid video contestin gyne-onco surgery for young surgeons

RULES & GUIDELINES AVAILABLE ON THE WEBSITE

14:00 CLOSING REMARKS Dr. Francisco Javier de Santiago MD Anderson Cancer Center Madrid, Spain Dr. Robert L. Coleman The University of Texas MD Anderson Cancer Center, Houston, USA Dr. Raúl Márquez MD Anderson Cancer Center Madrid, Spain

VENUE:

Auditorio Duques de PastranaPaseo de la Habana, 208 · 28016 Madrid (Spain)

ORGANIZED BY:

LANGUAGE:

Simultaneous translation English/Spanish will be provided

MEETING SECRETARIAT:

E-mail: [email protected]:+34 91 372 02 03

ACCREDITATION:Applications for CME credits have been forwarded to the Spanish Accreditation Council for Continuing Medical Education and to the Accreditation Council for Oncology in Europe (ACOE). ACOE accreditation is endorsed by EACCME®, the European Accreditation Council for Continuous Medical Education, an institution of the European Union of Medical Specialists (UEMS). �e UEMS-EACCME® and the AMA (American Medical Association) recognize each other’s CME credits.

With the collaboration of the Educational Committee of the MD Anderson Cancer Center Madrid.

in gynecologic cancers madrid, 11 may, 2018 · meeting directors: dr. francisco javier de santiago...

Documents